The Valley Hospital Ranked as One of New Jersey’s Top Research Centers by NJBIZ


RIDGEWOOD, NJ, April 8, 2024 – The Valley Hospital has been ranked as one of New Jersey’s top research centers by NJBIZ. The annual list generated by NJBIZ, New Jersey’s leading business journal, is ranked by the number of individuals at a Center who participate in research.

The Valley Hospital’s position was based on the 36 Valley staff members who are involved in biomedical and translational research at the Okonite Research Center. Recognized alongside Valley were:

  • Hackensack Meridian Health
  • Pfizer, Inc.
  • Montclair State University
  • New Jersey Institute of Technology
  • Rutgers Cancer Institute of New Jersey
  • Kessler Foundation
  • Stevens Institute of Technology
  • Coriell Institute for Medical Research
  • The Stem Cell Research Center and W.M. Keck Center for Collaborative Neuroscience Institute of New Jersey
  • Exelus, Inc
  • North Jersey Aids Alliance Inc. dba North Jersey Community Research Initiative (NJCRI)
  • NEI Corp.
  • Standford Investment Group
  • Advanced Clinical Institute Inc.
  • Metrofuser
  • Future Entheogenic Medicines, LLC

A full list, with research center details, has been published in NJBIZ magazine, Volume 37, number 12.

The Okonite Research Center serves as Valley’s home for research and clinical trials. The state-of-the-art center provides a centralized, dedicated space for our teams to conduct leading-edge research. Research and clinical trials are also conducted at The Valley Hospital and Valley-Mount Sinai Comprehensive Cancer Care.

“We are proud to be named among the top research centers in the state by NJBIZ,” said Ephraim Casper, MD, Chief Medical Officer for Valley-Mount Sinai Comprehensive Cancer Care. “Research is essential to improved outcomes for patients. Our team conducts research in several clinical areas, including oncology, gastroenterology, cardiology, infectious diseases, pulmonology, rheumatology, and neurology. Valley is also committed to increasing diversity, equity, and inclusion in our clinical research. We are developing initiatives aimed at increasing recruitment and retention of traditionally underrepresented groups.”

“In addition to highlighting Valley’s role as a top research center in New Jersey, this ranking underscores our commitment to responsible research,” said Suneet Mittal, MD, Director of Cardiac Research and Chair of the Cardiovascular Service Line for Valley Health System. “Our team ensures all research initiatives and clinical trials meet rigorous regulatory standards. We also keep patients informed on the risks and benefits associated with participation.”

To learn more about research and clinical trials at Valley, please visit ValleyHealth.com/Research.

  • Currently 0.00/5
Rating: 0.00/5 (0 votes cast)

Share It!

Be the first to comment